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Perspective
Disruption of dystrophin or the sarcoglycans within the 
dystrophin protein complex leads to muscular dystro-
phy. The dystrophin complex is enriched in myofibers 
and concentrated into costameres, rib-like structures in 
the plasma membrane. In the absence of dystrophin, 
the  plasma  membrane  becomes  fragile  with  reduced 
stiffness and increased leakiness, and exposing dystro-
phin-deficient muscle to hypoosmotic conditions pro-
duces membrane blebbing. These features are associated 
with an increase in intracellular calcium, reactive oxy-
gen species (ROS), and activation of a protease cascade. 
The ensuing loss of myofibers, largely mediated by a ne-
crotic cell death process, is associated with progressive 
replacement of the myofibers by fibrosis. Although 
membrane repair mechanisms may be activated, appar-
ently repaired myofibers may exhibit defective function 
from the intracellular consequences of membrane dis-
ruption. Additionally, remodeling of the extracellular 
matrix for those surviving myofibers may also adversely 
affect muscle function. Thus, the causes of muscle weak-
ness in muscular dystrophy are multifold and encom-
pass the matrix, membrane and intracellular elements 
of muscle identifying multiple target pathways for thera-
peutic intervention.
Introduction
The muscular dystrophies are a group of genetic diseases 
characterized by muscle weakness. The most common 
form, Duchenne muscular dystrophy (DMD), results 
from  loss-of-function  mutations  in  dystrophin.  Dystro-
phin encodes a 427-kD protein that resides below the   
sarcolemma. Together with its associated proteins, dys-
troglycan and the sarcoglycans, dystrophin participates 
in a mechanically strong link from the matrix to the un-
derlying  cytoskeleton  (Rybakova  et  al.,  2000).  Loss-of-
function mutations in the genes encoding , , , or   
 sarcoglycan result in autosomal recessive muscular dys-
trophies that phenotypically resemble DMD. Mutations 
in the genes encoding dystroglycan-glycosylating enzymes 
are linked to congenital forms of muscular dystrophy, 
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emphasizing the importance of dystroglycan’s connec-
tion to the extracellular matrix.
Boys with DMD are born with normal muscle func-
tion; however, as they age, they become progressively 
weaker. Muscle biopsies from young ambulatory chil-
dren with DMD show a mixed picture of degenerating 
myofibers alongside regenerating myofibers. Ongoing 
regeneration occurs in muscular dystrophy from activa-
tion of satellite cells, or muscle stem cells. Satellite cells 
divide and differentiate into myoblasts that may fuse 
with each other or to damaged myofibers. Muscle biop-
sies taken from older DMD patients with less mobility 
show fewer myofibers with far more replacement of the 
muscle tissue by adipose and connective tissue, referred 
to as fatty-fibrous infiltrate. The role of exercise in pro-
moting muscle injury in muscular dystrophy remains 
controversial. The diaphragm muscle is in constant use 
and often displays the most severe pathology, especially 
in animal models of muscular dystrophy, leading many 
to conclude that exercise exacerbates degeneration. 
The heart, also under constant activity and also affected 
by the loss of dystrophin and sarcoglycans, has a lagging 
pathology  compared  with  skeletal  muscle,  where  pa-
tients and animal models show signs of cardiac dysfunc-
tion later in life.
Without  question,  much  of  muscle  dysfunction  in 
later-stage muscle dystrophy arises from an absence of 
functional myofibers. However, the degree to which in-
tact muscle has normal function in muscular dystrophy 
remains in question. In intact muscle, dystrophin is re-
quired for protection from contraction-induced injury. 
Muscle that lacks a functional dystrophin complex is 
mechanically weak, such that when it contracts, it dam-
ages the membrane (Cox et al., 1993; Petrof et al., 
1993). Loss of membrane integrity likely contributes to 
dysfunction of the affected myofiber through multiple 
pathways. Disruption of the plasma membrane triggers 
a cascade of events, some of which are reparative such 
as  satellite  cell  activation  and  intracellular  resealing 
events. However, some intracellular consequences such 
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the calponin binding domain at dystrophin’s amino ter-
minus, but also through the basic residues in spectrin 
repeats  11–14  in  a  lateral  association  (Amann  et  al., 
1998). Peeled membrane from the myofibers of the mdx 
mouse that lacks dystrophin was not found to retain ac-
tin. Peeled membrane from the laminin 2-deficient dy 
mice retained both dystrophin and actin, indicating a 
specific role for dystrophin in the actin-binding inter-
face.  Recently,  it  was  shown  that  dystrophin  directly 
binds to tubulin and organizes the microtubule network 
(Prins et al., 2009). Because microtubules not only pro-
vide cell structure, but also scaffold the Golgi network 
and direct intracellular traffic, loss of this dystrophin–
microtubule interaction is a plausible mechanism for 
the altered localization of many proteins in dystrophin-
mutant animals.
Because of dystrophin’s role as a scaffolding protein 
integral to membrane integrity, multiple means of induc-
ing stress and strain on myofibers have been tested. When 
isolated myofibers from mdx mice were placed in hypoos-
motic medium, the membrane was observed to separate 
from the cytoskeleton in “blebs,” and the cells hypercon-
tracted resulting in cell death (Menke and Jockusch, 
1991). The difference between normal and dystrophin-
deficient muscle disappeared when the actin cytoskele-
ton was first disrupted with cytochalasin D, demonstrating 
the necessity of actin for the osmotic response. Curiously, 
sarcoglycan-deficient  myofibers  also  developed  blebs 
when subjected to hypoosmotic shock, despite the pres-
ence of dystrophin (Iwata et al., 2005). In support of this 
structural  role  for  dystrophin,  mdx-derived  myotubes 
were found to be less stiff than myotubes from normal 
mice when probed with a glass stylus (Pasternak et al., 
1995).  The  degree  to  which  reduced  stiffness  derives 
from the specific loss of dystrophin and/or the disrup-
tion of the sarcoglycan–dystroglycan complex is not clear. 
However, these abnormal membrane properties translate 
to defective membrane integrity in vivo.
Mechanical properties of dystrophic muscle
Most commonly, ex vivo studies have been used to deter-
mine active and passive properties of the dystrophin-defi-
cient muscle. Active properties of mdx muscle, such as 
twitch and tetanic force, are normal in mdx muscle, as are 
passive mechanical properties (Wolff et al., 2006). How-
ever, other studies have supported a decrease in specific 
twitch force in the mdx diaphragm muscle (Stedman et 
al., 1991). The decrease in specific force was also ob-
served in limb skeletal muscle from animals lacking   
 sarcoglycan (Sgca-null mice) (Duclos et al., 1998). More 
specifically, twitch force is preserved, but the cross-sec-
tional area is increased, thus reducing specific force. Fi-
ber cross-sectional area is calculated based on the mass 
and length of the muscle, and the increase in area in 
Sgca-null muscle is due to increased mass. It is possible 
that increase in mass is accounted for by increases in   
as Ca
2+ influx and increased ROS may have direct dele-
terious consequences for sarcomere function.
Membrane fragility
Dystrophin, and its associated proteins, are found at the 
sarcolemma in register with the sarcomeric Z disc in 
structures known as costameres (Fig. 1). Costameres   
reside  over  the  Z  disc  within  the  plasma  membrane   
perpendicular to the long axis of the myofiber. This in-
tracellular position, and the capacity of dystrophin to 
bind actin, argues for a role in transmitting force from 
the sarcomeres to the extracellular matrix and neigh-
boring cells. Rybakova et al. (2000) demonstrated that 
peeled membrane from normal myofibers retains cyto-
skeletal actin on its inner cytoplasmic face, underscor-
ing the tight linkage of dystrophin and actin. The link 
between dystrophin and actin is not only mediated by 
Figure 1.  Effect of dystrophin loss of myofiber function and or-
ganization. (A) Normal myofiber and (B) dystrophin-deficient 
mdx myofiber. Dystrophin and associated proteins are normally 
found at the rib-like costameres linking sarcomeric Z bands with 
the plasma membrane. Loss of dystrophin results in disorganized 
costameres and enhanced membrane leak. Increased edema and 
inappropriate cytosolic Ca
2+ and ROS generation (filled circles 
and diamonds) contribute further to muscle dysfunction. In-
creased extracellular matrix deposition surrounding myofibers 
also occurs and perturbs membrane integrity. This interaction is 
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assayed as creatine kinase, into the circulation. However, 
other proteins also leak into the serum, including lactate 
dehydrogenase and aldolase, and these serum proteins 
are effective as biomarkers of disease. It is unclear 
whether the leak of these myo-enzymes contributes to 
muscle  dysfunction  in  muscular  dystrophy.  Disrupted 
membrane integrity also promotes entry of small mole-
cules into the myofiber syncytium. The availability of 
Ca
2+-sensitive dyes has been used effectively to trace cal-
cium entry into muscle cells (Wang et al., 2005). The vital 
tracer Evans blue dye is a small molecule that gains entry 
into muscle lacking dystrophin, where normal fibers are 
typically impermeable (Matsuda et al., 1995). In vivo,   
Evans blue dye circulates in the vasculature, complexes 
with albumin, and then extravasates into the muscle. 
The  albumin–dye  complex  is  visualized  in  subsets  of 
myofibers, indicating membrane breakdown of those fi-
bers. Ex vivo, incubation of dye alone with muscle sec-
tions  on  a  slide  also  marks  the  subset  of  dye-positive 
fibers and reflects an accumulation of albumin that 
occurred in vivo in dystrophic fibers. Both in vivo and   
ex vivo, dye uptake occurs focally throughout the muscle 
where clusters of myofibers are dye-positive and the sur-
rounding myofibers remain dye-negative. Evans blue 
dye-positive  fibers  may  also  be  positive  for  apoptotic 
markers (Matsuda et al., 1995), although quite clearly 
only  a  minority  of  dye-positive  fibers  are  undergoing 
apoptosis (Hack et al., 1998).
The mechanism to account for focal disruption of 
membrane integrity is not well understood but could 
relate to biomechanical weakness in muscle where cer-
tain aspects of the muscle are more prone to damage. 
Alternative mechanisms such as regional vascular spasm 
have been used to explain patchy involvement of groups 
of myofibers. The entry of albumin–dye complexes im-
plies that myofibers develop holes large enough to ad-
mit an 70-kD protein and survive, at least temporarily. 
It may also have implications for drug studies in that 
disrupted or damaged cells may develop a much higher 
intracellular concentration, or any fiber with a disrupted 
dystrophin complex may be more permeable to drugs. 
During stimulated ex vivo contraction, uptake of the 
dye Procion orange can be readily detected in mdx mus-
cle,  although  this  dye  usually  indicates  cell  necrosis 
(Petrof et al., 1993).
Calcium and its sequelae
The prospect of large holes allowing entry of extracellu-
lar molecules, including generous amounts of Ca
2+, is 
reminiscent of classical excitotoxicity models of ischemic 
damage in which high intracellular calcium swells cells, 
activates intracellular proteases, deranges signaling, and 
quenches the mitochondrial membrane potential. Con-
sidering the large spike and fall in intracellular [Ca
2+] 
that occurs in contracting striated muscle, it makes sense 
to consider the significance of Ca
2+ in a larger context. 
water content and extracellular matrix deposition rather 
than sarcomere content (Consolino et al., 2005). In-
creased  water  content  or  edema  could  be  due  to  in-
creased intracellular ions, primarily Na
+, which may enter 
via membrane holes, the Na
+/Ca
2+ exchanger, or through 
nonselective transient receptor potential channels. This 
finding is somewhat complicated by histological studies 
of these mice that show that fibers are more numerous 
and of the same median size in Sgca-null mice. This could 
be explained by loss of the responsible ions during tissue 
processing (Consolino et al., 2005).
Another series of studies has focused on force deficits 
after eccentric contraction or lengthening contraction 
experiments. In this ex vivo protocol, isolated muscles 
are lengthened and stimulated to maximally contract, 
thus mimicking in vivo exercise such as downhill walk-
ing. The decrement in maximum force achieved after 
five repeated contractions is measured. With such proto-
cols, normal muscle exhibits 10% reduction in force 
from the first to the fifth contraction. In contrast, mdx 
muscle  shows  a  much  larger  decrease  (Petrof  et  al., 
1993), and this decrease is attributed to the loss of dys-
trophin’s normal scaffolding and support properties for 
the  plasma  membrane  of  muscle.  Enhanced  contrac-
tion-induced damage is also present in limb and dia-
phragm muscles from  sarcoglycan–deficient mice, but 
it is less than what is observed in mdx muscle (Hack et al., 
2000). Curiously,  sarcoglycan–null mice do not have 
contraction-induced damage, yet they display membrane 
leak and phenotypic features similar to mdx (Hack et al., 
1999). This finding suggests that the dystrophin com-
plex has a role beyond simple scaffolding and mechani-
cal support. In sarcoglycan-mutant mice, dystrophin is 
still present, but only the sarcoglycan complex is dis-
rupted, whereas in dystrophin-deficient muscle, both 
dystrophin and the sarcoglycan complex are disrupted. 
The sarcoglycan complex has been proposed to stabilize 
the interaction between the dystroglycan subunits, and 
thereby modify attachment to the matrix via dystrogly-
can. The extracellular components of the sarcoglycan 
complex contain modified cysteine-rich epidermal-like 
growth factor repeats and may themselves mediate inter-
action with matrix elements. The cysteine-rich units in 
sarcoglycan are essential because point mutations affect-
ing  only  these  residues  result  in  muscular  dystrophy. 
Most ex vivo muscle mechanical experiments have used 
muscle from younger animals (6–20 wk of age) where 
the muscle has a measurable increase in fibrosis, but this 
muscle does not carry the heavy fibrotic burden seen in 
older muscle. Progressive deposition of matrix around 
myofibers  may  also  contribute  to  muscle  dysfunction 
(see below).
Membrane leak and rupture
One noted feature of DMD and limb girdle muscular 
dystrophies is the release of muscle enzymes, generally 32 Muscle weakness in muscular dystrophy
is that Ca
2+ induces mitochondrial production of ROS 
via NADPH oxidase (Whitehead et al., 2008). Reduc-
tion in ROS using the membrane-permeant antioxidant 
N-acetylcysteine reduced the force decrement in mdx 
muscle after eccentric contraction and decreased cen-
tral nuclei when it was provided in the drinking water. 
ROS are hypothesized to activate signaling via nuclear 
factor B or ROS-sensitive kinases, leading to inflamma-
tion and altered cytoskeleton. ROS may also contribute 
to muscle dysfunction by directly oxidizing contractile 
proteins or sarcolemmal lipids.
The extracellular matrix in muscle pathology  
in muscular dystrophy
Patients with muscular dystrophy experience an abso-
lute decrease in muscle force, not only relative to mus-
cle size and not only after traumatic stretch. So, at best, 
even late stages of the mouse phenotype represent an 
early stage of the human disease. There are several po-
tential explanations for the difference in human and 
mouse phenotypes, including larger muscle size and in-
creased number of slow-twitch fibers, and these are dif-
ficult to investigate. In addition to species differences in 
disease course, there are also striking differences within 
the human muscular dystrophy population. When com-
paring patients with the identical gene mutations, there 
may  be  substantial  differences  in  the  amount  and 
progression of muscle weakness. These differences may 
arise from environmental factors such as size of muscle 
mass and exercise and diet. The range of muscle pheno-
type may also be due to difference in other genes that 
alter the function of the dystrophin complex or the re-
sponse of muscle to injury or regeneration. These ge-
netic modifiers are easier to study in mouse models of 
muscular dystrophy, despite limitations of the small ani-
mal model.
Using a mouse model of limb girdle muscular dystro-
phy lacking  sarcoglycan, a genome-wide scan was un-
dertaken to identify genes that modify the outcome in 
muscular dystrophy. The approach identified Ltbp4, a 
gene that encodes the latent transforming growth fac-
tor (TGF)-–binding protein, as a modifier of muscular 
dystrophy (Heydemann et al., 2009). This protein re-
sides in the extracellular matrix, where it binds to the 
cytokine TGF-. Proteolytic cleavage of LTBP4 results in 
release of TGF-, making it available to bind to TGF-   
receptors on myofibers and other cells within the mus-
cle. The protease-sensitive domain of LTBP4 was found 
to vary among mouse strains, and this difference corre-
lated with the amount of Evans blue dye uptake into 
muscle and the amount of fibrosis in dystrophic muscle. 
This variation in LTBP4 did not affect normal muscle. 
The correlation of TGF- activity with fibrosis is not so 
surprising, given the well-known role of TGF- family 
members in mediating fibrosis in many different cell 
and tissue types. What is more surprising is that the 
There are varying reports on resting Ca
2+ in isolated mdx 
fibers (Turner et al., 1988, 1991; Fong et al., 1990; Hopf 
et al., 1996). In vitro studies of isolated myofibers consis-
tently report an increase in Ca
2+ sparks in mdx muscle, 
especially when subjected to stress, such as hypoosmolar 
conditions (Wang et al., 2005). Sparks are also detected 
in myofibers isolated from mdx mice that were exercised, 
even mildly; however, Ca
2+ sparks only appear in normal 
myofibers if the fibers were exercised to fatigue (Wang 
et al., 2005). Interestingly, calcium sparks and the ad-
verse hypoosmotic response are not dependent on exog-
enous calcium, implying that an alternative intracellular 
source, such as the sarcoplasmic reticulum, may be criti-
cal. Sparks can be inhibited by the alkaloid ryanodine, 
which has focused attention specifically on RYR1 (Wang 
et al., 2005; Bellinger et al., 2009). In muscular dystro-
phy, Ca
2+ release by RYR is thought to become uncou-
pled  from  excitation  (Bellinger  et  al.,  2009).  This  is 
thought to be due to dissociation of FKBP12 from the 
RYR  complex.  This  dissociation  can  be  inhibited  by   
introduction of the small molecule S-107. Systemic ap-
plication of S-107 in mdx mice, either by continuous in-
fusion pumps or in drinking water, reduced the severity 
of the mdx phenotype by several measures. These mea-
sures included reduction in calcium spark frequency in 
isolated fibers, decreased numbers of fibers with central 
nuclei,  and  increased  grip  strength  (Bellinger  et  al., 
2009). These findings support a model in which calcium 
dysregulation causes increased myocyte death and gross 
muscle dysfunction. Surprisingly, S-107 treatment also 
reduced serum creatine kinase and Evans blue dye up-
take (Bellinger et al., 2009). The mechanism by which 
RYR stabilization results in increased membrane integ-
rity is unclear.
An alternative proposed source of Ca
2+ in dystrophic 
fibers  is  the  transient  receptor  potential  canonical 
(TRPC) channels. These have been variously proposed 
as sources of mechanosensitive, leak, sarcoplasmic re-
ticulum Ca
2+ depletion–mediated (store-operated), or 
calcium-induced Ca
2+ currents. This confusion owes to 
the redundancy of channels and the lack of specificity 
of current transient receptor potential inhibitory drugs. 
Overexpression of TRPC3 increases Ca
2+ uptake into 
muscles and was sufficient to cause some aspects of mus-
cular dystrophy (Millay et al., 2009). These include cen-
tral nuclei, fibro-fatty infiltrate, and muscle wasting with 
age. However, it is not clear that this approach repro-
duces the sarcolemmal fragility such as that seen with 
disruption of the dystrophin complex. Overall, this 
model is consistent with the role of elevated Ca
2+ entry 
as an intermediate event in muscular dystrophy. The in-
troduction of a dominant-negative TRPC6 reduced cal-
cium uptake in  sarcoglycan (Sgcd)–null muscle fibers 
and fibrosis (Millay et al., 2009).
Multiple mechanisms have been proposed for Ca
2+-
mediated muscle dysfunction. One promising explanation   Goldstein and McNally 33
extensive  evidence  of  altered  ion  handling,  and  the 
RYR-stabilizing drug S-107 improves membrane func-
tion (Bellinger et al., 2009). Conversely, decreasing Ca
2+ 
leak  with  dominant-negative  TRPC6  reduces  fibrosis 
and serum creatine kinase levels in muscular dystrophy 
(Millay et al., 2009). The increased water mass, or edema, 
in Sgca-null muscle implies some cell physiological de-
fect, but the degree to which this contributes must be 
further explored (Consolino et al., 2005). It is also un-
clear  whether  extracellular  matrix  changes  decrease 
force per se, or whether fibroblasts and extracellular 
matrix proteins simply prevent the formation of replace-
ment  muscle  by  occupying  former  muscle  niches  or 
forcing muscle stem cells to transdifferentiate to myofi-
broblasts (Li et al., 2004).
Future efforts will focus on interactions between the 
molecular processes that underlie the disease and place 
them in the order of their activation. It will also be impor-
tant to determine which experimental findings are cen-
tral to the disease process and thus are reasonable to 
target for therapeutic intervention. In the medium term, 
RYR stabilization or TGF- inhibition, through S-107, 
losartan, or other means, is useful for treating larger ani-
mal models or humans with muscular dystrophy.
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amount of TGF- activity and Ltbp4 gene variants strongly 
correlated with the degree of Evans blue dye uptake. 
Because Evans blue dye is a direct reflection of mem-
brane permeability in muscle, this finding indicates that 
LTBP4 regulates membrane integrity in myofibers. The 
mechanism by which LTBP4 may do this is unknown, 
but its position in the matrix argues for a role external 
to myofibers and potentially a direct interaction with 
the extracellular face of the myofibers.
Muscle from DMD patients is known to express in-
creased levels of TGF-, and protein can be localized 
within the extracellular matrix (Bernasconi et al., 1995). 
TGF- drives the synthesis of collagen and promotes the 
growth and differentiation of fibroblasts. It was proposed 
that in muscular dystrophy, myocyte necrosis or injury 
leads to TGF- signaling, which promotes fibrosis at the 
expense of regeneration by satellite cells. TGF-1 is ca-
pable of converting myoblast cells into myofibroblasts, 
raising the possibility that satellite cells are activated but 
differentiate into noncontractile tissue (Li et al., 2004). 
Phosphorylated SMAD2/3, an indication of TGF- sig-
naling, is present in mdx muscle fibers (Cohn et al., 
2007). Antibodies that inactivate TGF- or the angioten-
sin  II  receptor  blocker  losartan,  which  indirectly  de-
creases TGF- secretion, reduced SMAD signaling and 
decreased the severity of the mdx phenotype, including 
improved grip strength (Cohn et al., 2007).
Dystrophic muscle has a substantial mononuclear cell 
infiltrate that includes macrophages, lymphocytes, neu-
trophils, and eosinophils. The role of these immune cells 
is increasingly being considered in the pathogenesis of 
muscular dystrophy. For example, these cells are a likely 
source of proteases responsible for LTBP4 cleavage and 
subsequent TGF- activation. Recently, Vetrone et al. 
(2009) identified a subset of T cells specifically associated 
with dystrophic skeletal muscle. These cells display T cell 
receptors with the V8.1/8.2 rearrangement and express 
the  extracellular  matrix  phosphoprotein,  osteopontin. 
Deletion of osteopontin had several positive effects in the 
mdx mouse. Neutrophil invasion into the muscle was sig-
nificantly reduced, and the number of immune-suppress-
ing T lymphocytes, T regulatory cells, was increased. 
Overall, deleting osteopontin decreased TGF- and fi-
brosis, and it increased grip strength in the mdx mouse.   
A more balanced view of the immune system, including 
T regulatory cells, is required in muscular dystrophy and 
is the subject of ongoing investigation.
Perspective
It is clear that multiple interacting molecular processes 
occur in dystrophic muscle as it transitions from its nor-
mal appearance and function at birth to the completely 
dysfunctional state of end-stage muscular dystrophy. 
Several questions remain. The first is whether fiber 
dysfunction  contributes  significantly  to  muscle  weak-
ness, or whether only loss of fibers contributes. There is 34 Muscle weakness in muscular dystrophy
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